文献速递心境障碍会诊联络精神医学

重性抑郁障碍与躯体疾病共病:流行病学、机制与管理的综合综述

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management.
PubMed 文献 · World Psychiatry · 2023-01-01

本综述聚焦重性抑郁障碍(MDD)与心血管疾病、癌症、神经退行性疾病等常见躯体疾病的共病现象,指出共病率显著高于一般人群且双向风险增加。文章系统梳理了共病的流行病学、共享遗传与生物学通路(炎症、肠道菌群、线粒体功能、HPA轴失调、脑结构与功能)、社会与环境因素,以及药物、心理、生活方式、协作护理和数字技术等管理策略。

要点

  • MDD与常见躯体疾病存在高共病率及双向风险,共病与更差结局、治疗依从性降低和死亡率增加相关。
  • 共享生物学通路涉及炎症、肠道菌群、线粒体功能、HPA轴失调及脑结构与功能。
  • 药物与心理治疗对共病MDD有效,生活方式干预、协作护理和数字技术为有前景的管理策略。

核心结论

  • MDD与常见躯体疾病共病率高且呈双向风险,与更差结局、治疗依从性降低、死亡率增加及医疗利用和费用增加相关。

研究设计与样本

  • 本文为综合综述,旨在详细概述MDD与特定躯体疾病共病的流行病学、共享生物学通路、社会与环境因素及管理。

主要发现

  • 常见躯体疾病人群的MDD患病率显著高于一般人群,而MDD患者罹患多种躯体疾病的风险也更高。
  • 共病涉及共享遗传与生物学通路,包括炎症、肠道菌群、线粒体功能与能量代谢、HPA轴失调及脑结构与功能。
  • MDD与躯体疾病共享社会因素(如社会经济地位)、生活方式变量(如体力活动、饮食、睡眠)和应激生活事件(如童年创伤)等 antecedents。

临床怎么用

  • 药物和心理治疗对共病MDD有效,可结合生活方式干预、协作护理模式和数字技术优化管理。
  • 临床需关注共病带来的治疗联盟复杂化、适应性健康行为问题、药物相互作用及药物不良事件等挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Populations with common physical diseases - such as cardiovascular diseases, cancer and neurodegenerative disorders - experience substantially higher rates of major depressive disorder (MDD) than the general population. On the other hand, people living with MDD have a greater risk for many physical diseases. This high level of comorbidity is associated with worse outcomes, reduced adherence to treatment, increased mortality, and greater health care utilization and costs. Comorbidity can also result in a range of clinical challenges, such as a more complicated therapeutic alliance, issues pertaining to adaptive health behaviors, drug-drug interactions and adverse events induced by medications used for physical and mental disorders. Potential explanations for the high prevalence of the above comorbidity involve shared genetic and biological pathways. These latter include inflammation, the gut microbiome, mitochondrial function and energy metabolism, hypothalamic-pituitary-adrenal axis dysregulation, and brain structure and function. Furthermore, MDD and physical diseases have in common several antecedents related to social factors (e.g., socioeconomic status), lifestyle variables (e.g., physical activity, diet, sleep), and stressful live events (e.g., childhood trauma). Pharmacotherapies and psychotherapies are effective treatments for comorbid MDD, and the introduction of lifestyle interventions as well as collaborative care models and digital technologies provide promising strategies for improving management. This paper aims to provide a detailed overview of the epidemiology of the comorbidity of MDD and specific physical diseases, including prevalence and bidirectional risk; of shared biological pathways potentially implicated in the pathogenesis of MDD and common physical diseases; of socio-environmental factors that serve as both shared risk and protective factors; and of management of MDD and physical diseases, including prevention and treatment. We conclude with future directions and emerging research related to optimal care of people with comorbid MDD and physical diseases.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Berk M, Köhler-Forsberg O, Turner M, et al. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023. PMID: 37713568. doi:10.1002/wps.21110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。